Virus

As nanoscale pathogens with high structural specificity and replication capability, viruses are extensively utilized in various domains, including molecular biology, vaccine development, and gene therapy. Virus-like particles (VLPs), which are hollow structures formed through the self-assembly of viral structural proteins, exhibit safety and immunogenicity, making them indispensable for vaccine research and drug delivery systems. Both viruses and VLPs serve as critical tools in fundamental scientific investigations aimed at elucidating cellular mechanisms and discovering innovative therapeutic strategies. EXODUS is capable of rapidly eliminating impurities such as free nucleic acids and proteins from samples while efficiently retaining viruses and VLPs, thereby achieving their enrichment and purification. Additionally, it effectively preventing particle aggregation and membrane clogging during the purification process. By employing a low-shear-force purification method, EXODUS ensures the production of target products with high purity and biological activity, significantly enhancing experimental efficiency and result consistency. Consequently, EXODUS represents an optimal solution for virus purification.